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2Abstract 
Genome-wide linkage analysis and whole exome sequencing undertaken in two siblings with delayed 
psychomotor development, absent speech, severe intellectual disability and postnatal microcephaly, 
revealed a homozygous intragenic deletion in VPS51, which encodes the vacuolar protein sorting-
associated protein, one the four subunits of the GARP and EARP complexes that promotes the fusion 
of endosome-derived vesicles with the trans-Golgi network (GARP) and recycling endosomes 
(EARP). This observation supports a pathogenic effect of VPS51 variants, which has only been 
reported previously once, in a child with microcephaly. It confirms the key role of membrane 
trafficking in normal brain development and homeostasis.
Keywords:
VPS51, GARP, EARP, Golgipathies, Golgi, endosomes, postnatal microcephaly, neurodevelopmental 
disorders, Rwanda
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3Introduction
Neurodevelopmental disorders (NDDs) encompass a wide range of intellectual, behavioral and motor 
disabilities (van Bokhoven, 2011). High-throughput sequencing has allowed to more readily capture 
variations causing subtle or atypical phenotypes, especially in NDDs (Hu et al., 2014). Recently, the 
role of membrane trafficking during brain development and maturation has been highlighted with a 
central contribution played by the Golgi apparatus and its impact on key processes : neurogenesis, 
neuronal migration, myelination and maturation of postmitotic neurons ((Passemard et al., 2017; 
Rasika et al., 2019). In particular, the Golgi-associated retrograde protein (GARP) acts in promoting 
the retrograde fusion of endosome-derived carriers with the trans-Golgi network (TGN) (Bonifacino 
and Hierro, 2011; Conibear and Stevens, 2000; Perez-Victoria et al., 2010). GARP is a multisubunit 
complex made of four distinct proteins (VPS51, VPS52, VPS53 and VPS54). GARP differs only in 
one subunit with another tethering complex, known as the endosome-associated recycling protein 
(EARP) complex, in which the VPS54 subunit is substituted by syndetin (VPS50). EARP ensures the 
fusion of endosome-derived carriers with recycling endosomes and therefore promotes recycling of 
endocytic membranes back to the plasma membrane (Masschaele et al., 2017; Schindler et al., 2015). 
Among the five subunits of the GARP/EARP complexes, VPS53 was the first to be associated with a 
human disease. Loss-of-function mutations in VPS53 have been associated with two forms of 
degenerative NDDs, autosomal recessive pontocerebellar hypoplasia type 2E (PCH2E, MIM 
#615851), characterized by a severe early-onset neurodegeneration with profound intellectual 
disability (ID), progressive microcephaly, spasticity, and early-onset epilepsy (Feinstein et al., 2014), 
and progressive encephalopathy with edema, hypsarrhythmia and optic atrophy (PEHO) characterized 
by a severe developmental delay, limb and facial edema, intractable epilepsy, optic atrophy and 
dysmorphic features (Hady-Cohen et al., 2018). Recently, a 6-year-old patient with severe global 
developmental delay, pontocerebellar abnormalities, microcephaly, hypotonia, epilepsy and several 
systemic and peripheral dysfunctions has been reported (Gershlick et al., 2019). This girl was found to 
carry compound heterozygous variants in VPS51 affecting both GARP and EARP complexes. 
Here, we report two Rwandan sisters with a homozygous three base pairs intragenic deletion in 
VPS51 associated with developmental delay, absent speech, severe ID and postnatal microcephaly. 
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4The present study confirms the key role of the GARP and EARP complexes in normal brain 
development and homeostasis.
Patients and Methods
Patient 1
Patient 1, seen in the Centre of Medical Genetics of Rwanda University, in Kigali, was born to first-
cousin once removed parents of Rwandese origin (f=1/32), for severe psychomotor developmental 
delay. This girl was born by normal delivery from an uneventful pregnancy (birth weight: 3600 g). 
Head circumference was not recorded. At 1 month of age, she had a poorly described episode of fever 
with loss of consciousness treated by an unknown medication. Further development was severely 
delayed. She was able to sit unsupported at age 3. At the first academic evaluation, at age 5, she was 
still unable to walk and had no language. Clinical examination revealed microcephaly (head 
circumference of 46,5 cm: -3.23 SD), a weight of 15 kg (-1.36 SD) and a height of 118 cm (+ 1.8 SD). 
She had hypertelorism, upturned nasal tip, short philtrum, thick vermilion of the upper lip, large teeth 
(Fig. 1 A), high arched palate, multiple dental carries, left internal strabismus, and bilateral pes 
planus. Brain CT-scan showed Dandy Walker variant anomaly with a cyst of the posterior fossa, 
communicating with the 4th ventricle, and mild ventriculomegaly. At the age of 9, she had ataxic gait. 
The language was still absent. Brain MRI showed mild vermis atrophy, a thin corpus callosum, 
dilated lateral ventricles and a mega cisterna magna (Fig. 2 A,B). Serum transferrin isoelectrofocusing 
excluded congenital disorder of glycosylation (CDG).
Patient 2
Patient 1's sister was 30-month-old at examination (Fig 1 B). She was born at term following an 
uneventful pregnancy and delivery (birth weight 3200 g). At 12 months, she developed an episode of 
fever, diarrhoea and vomiting and became hypotonic. At 30 months, she was not able to walk and had 
no speech. Feeding difficulties at home lead to severe hypotrophy. She had upturned nasal tip and left 
internal strabismus (Fig 1 B). Her head circumference was 43 cm (- 4.56 SD), her weight was 7 kg (< 
-3 SD) and her height was 83 cm (- 2.3 SD). Brain MRI showed no malformation of the brain but a 
reduced white matter volume and a thin corpus callosum with a normal vermis (Fig. 2 C, D). 
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5Methods 
Genomic DNA was extracted from peripheral blood leukocytes using the standard phenol/chloroform 
method. Whole-genome SNP array was performed in patients, their parents and one unaffected sibling 
using HumanOmni2.5 BeadChip (Illumina, San Diego, CA). Fifty nanograms of DNA were processed 
according to Illumina’s Infinium HD Assay Super protocol. Arrays were scanned with an iScan 
System and data were extracted by the Genome Studio software (Illumina, San Diego, CA) and 
analysed using the PLINK software. Exome sequencing (WES) was performed in both patients and 
their parents. Library preparation, sequencing, alignment and variant calling were performed in the 
Unit of Human Genetics, GIGA, at the University of Liege (Belgium). Exons were captured using the 
Agilent SureSelect Human All Exon V5+UTR (Agilent Technologies, Santa Clara, CA, USA), and 
sequence was generated on a Hiseq2000 instrument (Illumina San Diego, CA, USA). Base calling 
was performed using the Illumina CASAVA software. All the raw reads were aligned to the reference 
human genome (GRCh37 / hg19) using the Burrows–Wheeler aligner (BWA). Optical and PCR 
duplicates were marked and removed with Picard tools (http://picard.sourceforge.net). Single 
nucleotide variants and small insertions/deletions were then called using the GATK Unified 
Genotyper v2.7. Variant annotation was performed using ANNOVAR. Variant screening was 
restricted to genes included in homozygous loci revealed by homozygosity mapping. Variants with at 
least a minor allele frequency (MAF) of 0,01% in dbSNP138, 1000 genomes, ExAC and ESP6500 
databases were excluded. Missense variants were tested for mutational effect by prediction algorithm 
with Polyphen-2, Sift, Provean, mutation taster, and CADD score. The analysis process was based on 
the latest release of GnomAD, dbSNP, ExAC databases and the literature review. The variant 
identified by WES was confirmed by Sanger sequencing in the patients and their parents (primers 
sequence available on request). The study was approved by the Rwandan National Ethics Committee 
(N°394/RNEC/2013) and informed consents were obtained from the participants.
Results
Homozygosity mapping revealed a large homozygous locus on chromosome 11 
(chr11:44,081,150_74,821,392) of about 30 Mb (11p11.2-q13.4) in both sisters. WES revealed a 
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6variant in the VPS51 gene (reference sequence : NM_013265.3) consisting in an in-frame deletion of 
a CTT codon in exon 5 (c.1419_1421del / p.(Phe474del) ) detected at the homozygous state in both 
sisters and at the heterozygous state in both parents and in the unaffected sister. Phe474 is a highly 
conserved residue. This mutation was present in only 2 individuals in the GnomAD database 
(MAF:0.00083%) and was never reported at the homozygous state.
Discussion
In this study, WES was performed in two patients from a Rwandan consanguineous family with 
NDD. Our patients were selected from a cohort of a previously analysed series of 50 Rwandan 
patients presenting ID and global development delay with or without dysmorphic features (Uwineza 
et al., 2014). The phenotype of our patients includes minor dysmorphic features, a severe global 
developmental delay, a microcephaly, and a reduced volume of the subcortical white matter 
associated with vermis atrophy in the eldest sister. 
Although the deletion identified in the present study does not induce a frameshift in the coding 
sequence of VPS51, the loss of the highly conserved Phe474 is predicted to impact the function 
and/or stability of the subunit, possibly by altering a site of interaction with other partners. 
Furthermore, this mutation has never been reported in patients of African origin suggesting that this 
mutation is not a rare polymorphism associated with an ethnic group. 
A single 6-year-old patient has recently been reported with compound heterozygous mutations 
(c.1468C>T/p.Asp745Thrfs*93 and c.2232delC/p.Arg490Cys) in VPS51 (Gershlick et al., 2019). 
The patient had failure to thrive, severe ID, microcephaly, thin corpus callosum, pontocerebellar 
abnormalities (small vermis and thin brainstem) and a Dandy-Walker variant. EEG showed electrical 
status epilepticus in sleep (ESES) requiring anticonvulsant therapy. She further had cortical blindness, 
chronic cholestasis requiring ursodiol treatment, edema of the lower limbs reminiscent of PEHO 
syndrome, and some dysmorphic features (including epicanthal folds, long eyelashes, upturned nasal 
tip, a thin upper lip, full cheeks, increased hair on the upper back. Isoelectric focusing showed a 
hypoglycosylated profile of serum transferrin Authors showed that the c.2232delC produces an 
unstable frameshifted protein 54 aminoacids longer than the wild type and that the c.1468C>T 
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7mutation produces a stable protein that assembles less efficiently with the other GARP/EARP 
subunits. In skin fibroblasts from the patient, the levels of fully-assembled GARP and EARP 
complexes were lowered. The distribution of the cation-independent mannose 6-phosphate receptor 
was altered and swelling of lysosomes was noted. Our patients appear thus to show a milder 
phenotype lacking epilepsy, the PEHO-like features (edema, optic impairment), the liver involvement 
and abnormal glycosylation profile of serum transferin. 
Clinical features of our patients also have similarities with those of patients reported with mutation in 
VPS53, such as microcephaly and developmental delay in patients presenting PCH2E (Feinstein et al., 
2014). However, our patients do not have epilepsy and their developmental delay is less severe than 
those with PCH2E. Interestingly, mutations in both VPS53 and SEPSECS, the gene for PCH2D 
(OMIM #613811), can result in PEHO-like phenotype or PCCA, suggesting that these conditions 
belong to a common clinical spectrum (Hady-Cohen et al., 2018). In agreement with these 
observations, defective Golgi proteins are increasingly linked to a wide spectrum of 
neurodevelopmental defects that have been recently classified as "Golgipathies" (Rasika et al., 2019) 
and that usually associate progressive microcephaly and ID with white matter defects. 
The observation of Gershlick and colleagues (Gershlick et al., 2019) that not only the proteasomal 
degradation of VPS51 but also a single aminoacid substitution in its sequence can result in a 
decreased stability and/or efficiency of the whole GARP and EARP complexes indicates that VPS51 
integrity is essential to GARP/EARP function. Of interest, the substitution reported in this paper is 
16-aminoacid close to the Phenylalanine deletion observed in the present study. On the other hand, a 
residual activity of GARP/EARP complexes is most likely necessary to avoid embryonic lethality and 
may explain why these NDDs, although very severe, are viable. Further studies are obviously required 
to validate the consequence of this mutation on both complexes.
Among the four subunits of the complex, VPS51 is required for the proper recruitment of GARP 
complex at the Golgi by promoting its interaction with the SNARE machinery (Conibear et al., 2003). 
In EARP, VPS51 likely plays a similar function in promoting SNARE-mediated membrane fusion 
events. VPS51 also assembles with the other three subunits of GARP/EARP complexes in a 
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8stoichiometric manner which implies that its instability likely compromises that of the whole 
complexes (Perez-Victoria et al., 2010). Therefore, VPS51 lies at the core of GARP/EARP complexes 
and thereby participates to many functions essential for cell homeostasis such as traffic and recycling 
of endosomes, acid hydrolase sorting, lysosome function, endosomal cholesterol traffic and autophagy 
(Perez-Victoria et al., 2010). That the phenotype resulting from the deficiency of these complexes is 
mainly neurodevelopmental is somehow surprising regarding their ubiquitous expression throughout 
life and their critical function in maintaining cellular homeostasis. The same issue has been raised and 
discussed recently for a number of Golgipathies (Rasika et al., 2019). More studies are now required 
to understand why the nervous system appears more vulnerable than other organs to the deregulation 
of the endomembrane system. 
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9Figures
Figure 1. 
Patient 1 (left) and 2 (right)
Figure 2. MRI of both siblings in T1 weight images (A,C: sagittal - B, D: axial).
A and B: MRI of the patient 1 at age 9; C & D MRI of the patient 2 aged 30 months. Note the 
thin corpus callosum and the reduced volume of white matter for both siblings. Cerebellum 
(vermis and lobes) shows atrophy in patient 1, whereas it is preserved in patient 2, 
suggesting a progressive atrophy with age.
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